Clinuvel Pharmaceuticals Ltd (CUV.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,572 | 14,626 | 12,569 | 17,808 | 12,178 |
| Marketable Securities | N/A | N/A | N/A | 454 | 5,321 |
| Receivables | 1,960 | 1,585 | 1,743 | 1,007 | 974 |
| Inventories | 837 | N/A | N/A | N/A | N/A |
| Other current assets | 70 | 0 | 0 | 0 | 0 |
| TOTAL | $13,575 | $17,039 | $15,668 | $20,896 | $19,932 |
| Non-Current Assets | |||||
| PPE Net | 69 | 114 | 146 | 179 | 215 |
| Intangibles | N/A | N/A | N/A | 9 | 18 |
| TOTAL | $69 | $114 | $146 | $188 | $233 |
| Total Assets | $13,644 | $17,154 | $15,815 | $21,084 | $20,165 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 261 | 178 | 184 | 839 | 1,697 |
| TOTAL | $2,435 | $1,718 | $1,946 | $2,339 | $3,717 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3 | 8 | 29 | 19 | 40 |
| TOTAL | $3 | $8 | $29 | $19 | $40 |
| Total Liabilities | $2,439 | $1,726 | $1,976 | $2,358 | $3,757 |
| Shareholders' Equity | |||||
| Common Shares | 138,465 | 133,567 | 126,710 | 119,323 | 113,339 |
| Retained earnings | -129,958 | -119,577 | -114,122 | -107,507 | -100,145 |
| Other shareholders' equity | 2,698 | 1,438 | 1,251 | 1,821 | 3,214 |
| TOTAL | $11,205 | $15,428 | $13,839 | $13,637 | $16,408 |
| Total Liabilities And Equity | $13,644 | $17,154 | $15,815 | $15,995 | $20,165 |